Latest NewsOct 7, 2024HiFiBiO Therapeutics to Showcase DIS® Enabled Translational Insights from Ongoing Phase 1 Clinical Trials for Two Novel Immuno-Oncology Antibodies at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)All Filter By: Year2024202320222021202020192018201720162015Aug 13, 2015HiFiBiO SAS Achieves Milestone in Antibody Research Collaboration with Pfizer Inc.Jun 12, 2015HiFiBiO to present platform at next-generation antibodies conferenceJun 12, 2015HiFiBiO partners with Johnson & Johnson Innovation< 1 … 15 16 17
